Clinical Updates in CLL and MCL

 

SOHO Highlights: State of the Art and Next Questions
Avatar

SOHO Highlights on R/R MCL: The Role of BTKis, CAR-T, and Chemotherapy on Treatment Outcomes

By SOHO Highlights: State of the Art and Next Questions FEATURING Jonathon Cohen
By SOHO Highlights: State of the Art and Next Questions FEATURING Jonathon Cohen
149 views
February 3, 2021
0 Comments
Login to view comments. Click here to Login
Clinical Updates in CLL and MCL
17:54
19th Annual International Ultmann Chicago Lymphoma Symposium

Debate: Auto-HCT Remains the Preferred Standard of Care for 1L Thera…

Feat. T. Fenske
17:53
19th Annual International Ultmann Chicago Lymphoma Symposium

Sequencing of Therapies in R/R MCL

Feat. K. Maddocks
06:32
ecancer

Primary Results of the Phase III SHINE Study: Ibrutinib in Combinati…

Feat. M. Wang
04:51
ecancer

EHA 2022 on Targeted Therapy Combinations With Venetoclax Superior t…

Feat. B. Eichhorst
04:29
ecancer

EHA 2022 Time-Limited Venetoclax-Obinutuzumab +/- Ibrutinib Surpasse…

Feat. B. Eichhorst
05:39
ASCO 2022 Conference Coverage

ASCO 2022 Treatment Patterns and Real-World Effectiveness of Rituxim…

Feat. M. Di
01:44
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Treatment Patterns and Real-World Effect…

Feat. M. Di
05:40
ASCO 2022 Conference Coverage

ASCO 2022 Brexucabtagene Autoleucel for R/R Mantle Cell Lymphoma: Re…

Feat. P. Jain
57
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Brexucabtagene Autoleucel for R/R Mantle…

Feat. P. Jain
13:49
Seema Bhat

Surveying BTKi-Related AEs in CLL: Cardiovascular Risk in Patients R…

11:39
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Data on the Resistance to BTKi in CLL

Feat. J. Woyach
09:11
Constantine Tam

SOHO 2021 Update on Resistance Mechanism to BCL-2 Inhibitors in CLL:…

15:54
Penn Medicine Abramson Cancer Center

2021 ASCO Updates on Lymphoma and CLL

Feat. J. Gerson
15:12
UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

63 y/o Male With MCL: What Initial Therapy to Choose? What Would Be …

Feat. A. Duvall, P. Riedell, B. Derman, S. Kosuri
19:43
SOHO Highlights: State of the Art and Next Questions

SOHO Highlights on R/R MCL: The Role of BTKis, CAR-T, and Chemothera…

Feat. J. Cohen
18:11
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on the Use of MRD in CLL: American Perspective

Feat. M. Davids
15:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Update on Dissecting the Biology of MCL: What Is Clinicall…

Feat. T. Witzig
21:44
ASH 2021 Conference Coverage on VuMedi

ASH 2021 Updates on Efficacy and AE Management of BTKi in CLL/SLL

Feat. J. Rhodes
11:06
ASH 2021 Conference Coverage on VuMedi

ASH 2021 MRD Assessment in CLL

Feat. P. Ghia
10:24
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on Optimal Treatment of MCL: Future Strategies

Feat. M. Dreyling